TL;DR
This study investigated depression rates and contributing factors in patients with both endometriosis and rheumatoid arthritis, finding that common depression screening tools are effective. Key factors influencing depression in this population include pain symptoms (dysmenorrhea, dyspareunia), disease activity, and impaired quality of life.
What Problem Does This Paper Address?
Endometriosis and rheumatoid arthritis are chronic conditions that significantly impact a patient's quality of life. Both conditions are independently associated with an increased risk of depression. When these two conditions co-occur, the burden on patients is amplified, and the risk of depression is likely even higher. However, there's a lack of research specifically examining the prevalence and influencing factors of depression in this comorbid patient group. This paper aims to fill that gap by exploring how effectively different diagnostic criteria detect depression and identifying the specific factors that contribute to it in patients with both endometriosis and rheumatoid arthritis.
Methods
The researchers conducted a retrospective study involving 108 patients diagnosed with both endometriosis and rheumatoid arthritis. They employed three different diagnostic tools to assess depression: the internationally recognized Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), the Hamilton Depression Scale (HAMD), and the Self-rating Depression Scale (SDS). Patients were then categorized into an "observation group" (with depression) and a "control group" (without depression) based on DSM-5 results. Clinical data, including demographic information, general health status, and specific symptom severity (pain, disease activity, sleep quality, functional impairment), were collected. Binary logistic regression analysis was used to identify significant influencing factors for depression.
Datasets
The study utilized data from 108 patients treated at the First Hospital of Lanzhou University between July 2021 and July 2023. This dataset is specific to patients with co-occurring endometriosis and rheumatoid arthritis. No external or publicly available datasets were used for training or evaluation.
Key Insights and Ideas
- Screening Tool Equivalence: The study found that the DSM-5, HAMD, and SDS are all effective and comparable tools for detecting depression in this specific patient population, with no statistically significant difference in their detection rates. This is important for clinical practice, as it suggests flexibility in choosing a screening method.
- Pain as a Major Driver: The research strongly highlights the role of pain symptoms, specifically dysmenorrhea (painful menstruation) and dyspareunia (painful sexual intercourse), as significant contributors to depression. This underscores the profound impact of endometriosis-related pain on mental well-being.
- Holistic Impact of Disease: Beyond direct pain, the study identified disease activity in rheumatoid arthritis (measured by DAS28) and overall functional impairment (measured by HAQ-DI) as crucial factors. This suggests that the systemic nature of these chronic conditions, affecting physical function and daily life, directly correlates with depressive symptoms.
- Sleep Quality Matters: Poor sleep quality, as assessed by the PSQI, emerged as another significant influencing factor. This aligns with the known bidirectional relationship between sleep disturbances and mood disorders.
Key Results
- Depression Detection Rates:
- DSM-5 detected depression in 18.52% of patients.
- HAMD detected depression in 19.44% of patients.
- SDS detected depression in 16.67% of patients.
- The differences in detection rates among these tools were not statistically significant (p = 0.865).
- Significant Influencing Factors for Depression (Odds Ratios):
- Dysmenorrhea: OR = 3.589 (p = 0.005)
- Dyspareunia: OR = 2.964 (p = 0.012)
- Visual Analog Scale (VAS) score: OR = 2.545 (p = 0.001)
- Disease Activity Score-28 (DAS28) score: OR = 3.828 (p = 0.004)
- Pittsburgh Sleep Quality Index (PSQI) score: OR = 3.942 (p = 0.004)
- Health Assessment Questionnaire-Disability Index (HAQ-DI) score: OR = 3.527 (p = 0.008)
- Demographic Differences: Patients in the observation group (with depression) were younger and had a higher proportion with lower educational attainment, a higher proportion of childless children, and shorter average sleep times compared to the control group.
Limitations and Future Work
The authors acknowledge several limitations:
- Cross-sectional Design: This design prevents the establishment of causal relationships; it can only show associations.
- Single-Center Study: The data was collected from one hospital, which may introduce selection bias and limit the generalizability of the findings to other populations.
- Unaccounted Factors: The study did not consider potential influencing factors such as patients' medication regimens and social support systems.
- Sample Size: The reported sample size did not meet the required statistical power for robustness, although the modeling was deemed successful.
For future research, the authors suggest adopting multicenter, large-sample, longitudinal designs. They also recommend incorporating biological markers and psychological assessment tools to further explore the mechanisms of depression in this population and validate additional influencing factors and intervention strategies.
Summary updated